Etihad Cargo, Envirotainer complete 10 years of partnership

Etihad Cargo, the cargo and logistics arm of Etihad Airways, has completed ten years of partnership with Envirotainer, a global market leader in secure cold chain solutions for air transport of pharmaceuticals.

"This milestone marks a decade of excellence in transporting temperature-sensitive pharmaceuticals across the globe, combining Etihad Cargo's comprehensive global network and expertise with Envirotainer's innovative container solutions," says an official release from Etihad Cargo.

Since the start of the partnership in 2013, Etihad Cargo has utilised Envirotainer's unit load devices (ULDs) to enhance the safety and quality of pharmaceutical shipments via the carrier's International Air Transport Association (IATA) Centre of Excellence for Independent Validators (CEIV)-certified PharmaLife product, the release added.

In 2023, Etihad Cargo utilised Envirotainer’s active containers on 134 percent more trips than the previous year. "The carrier also achieved a 37 percent increase in pharmaceutical and healthcare shipments, marking the highest volumes in Etihad Cargo's history. This growth demonstrates Etihad Cargo's continued investment in its infrastructure, product features and partnerships, which have enabled the carrier to contribute to creating a healthcare ecosystem in Abu Dhabi and a robust global pharma supply chain."

Thomas Schürmann, Head, Cargo Operations & Delivery, Etihad Cargo says: "Etihad Cargo's decade-long partnership with Envirotainer reflects the shared ongoing commitment to creating a more robust, resilient and transparent global healthcare ecosystem. Through this collaboration, Etihad Cargo has been able to ensure the seamless delivery of essential life-saving medicines to improve the lives of people around the world while overcoming logistical challenges and providing transparency."

Akos Balkanyi, Global Key Account Manager, Envirotainer adds: “This significant milestone highlights the true collaboration between our two companies and resonates with our mission of enabling global access to biopharmaceuticals. We look forward to continuing to work together to further strengthen and innovate the cold chain."